Pfizer and Dr. Robert Jarvik insist their use and promotion of Lipitor and Caduet do not violate Dr. Mathew Gelfand's patent on "use of thrombolytic reagents for prevention of vascular disease," which patent they say is invalid and unenforceable, in Manhattan Federal Court.
Breaking the Chain Foundation claims Capitol Educational Support violates its "Breaking the Chain" trademark, in DC Federal Court. Both groups say they are trying to eradicate intergenerational incarceration in the Capital Area.
Categories:Uncategorized
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.
Additional Reads
-
Groups make own drugs to fight high drug prices, shortages August 10, 2021 -
Supreme Court Narrows Process for Patent Reviews June 10, 2019
-
Lab Loses Its Breast Cancer Gene Patents June 13, 2013
-
Johnson & Johnson Sinks Stent Patent Verdict April 8, 2013